Imedrix Systems Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-01-2025
- Paid Up Capital ₹ 1.00 M
as on 13-01-2025
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.33 M
as on 13-01-2025
- Revenue 12.30%
(FY 2022)
- Profit 87.72%
(FY 2022)
- Ebitda 29.45%
(FY 2022)
- Net Worth 54.90%
(FY 2022)
- Total Assets -5.55%
(FY 2022)
About Imedrix Systems
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.33 M.
Nagesh Rangappan, Rajaram Shastri, Srikanth Jadcherla, and One other member serve as directors at the Company.
- CIN/LLPIN
U72300KA2016PTC086571
- Company No.
086571
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Imedrix Systems Private Limited offer?
Imedrix Systems Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, ECG Machine, Electrodiagnostic Instruments.
Who are the key members and board of directors at Imedrix Systems?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatakrishna Araveti  | Director | 01-Mar-2016 | Current |
| Rajaram Shastri | Director | 01-Mar-2016 | Current |
| Nagesh Rangappan | Director | 14-Mar-2020 | Current |
Srikanth Jadcherla  | Director | 28-Apr-2016 | Current |
Financial Performance of Imedrix Systems.
Imedrix Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.3% increase. The company also saw a substantial improvement in profitability, with a 87.72% increase in profit. The company's net worth Soared by an impressive increase of 54.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imedrix Systems?
In 2022, Imedrix Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Piitech Systems Private LimitedActive 11 years 2 monthsNagesh Rangappan, Rajaram Shastri and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Jul 2019 | ₹5.33 M | Open |
How Many Employees Work at Imedrix Systems?
Imedrix Systems has a workforce of 25 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imedrix Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imedrix Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
